Portfolio

Origine Portfolio.

Origine invests across two complementary strategies — Private Equity and Venture Capital — backing companies from early-stage innovation to established industrial growth.

Private Equity

Venture Capital

Origine Growth PE backs established Italian companies, leaders in their respective sectors, supporting their growth and international development.

F.lli Martini S.p.A. | BF International

Gruppo Martini is a long-established Italian operator in the agri-food supply chain, active in the production and marketing of animal feed, meat and food products, with a consolidated presence across the entire value chain. BF International is the platform of BF S.p.A. dedicated to developing integrated and sustainable agro-industrial projects in international markets. Origine Growth PE invested alongside BF S.p.A. and BF International to support Gruppo Martini's entry into the platform, backing its growth and international development. Subject to certain conditions, Origine Growth PE will hold a minority stake in BF International.

Q2 2026 · Minority

The Venture Capital fund's portfolio consists of minority stakes in international startups, primarily in the healthcare sector and — to a lesser extent — digital.

BetaGlue Technologies

A medtech company developing a loco-regional radiotherapy treatment for unresectable solid tumours. Its proprietary technology consists of a compound injected via a dedicated medical device that enables intratumoral radiotherapy through Yttrium-90 microspheres.

Q3 2016 · Stake 15.5%

CVLab

A venture builder focused on cardiovascular innovation, born from the collaboration between Innogest, serial entrepreneurs and investors specialised in the cardiovascular sector. Today CVLab includes four projects: Recross, Dyverto, Kapto and Fideliomed.

Q4 2016 · Stake 43.2%

Empatica

An MIT spin-off company developing medical-grade wearable devices and AI-based software for remote patient monitoring, supporting the detection and management of neurological conditions such as epilepsy and other chronic diseases.

Q4 2016 · Stake 14.3%

GreenBone Ortho

An Italian biomedical company developing innovative solutions for bone regeneration, using advanced bio-inspired materials for bone substitutes derived from natural structures, designed to support and accelerate the healing of complex bone defects.

Q2 2017 · Stake 10.8%

Pi-Cardia

An Israeli medical device company focused on catheter-based solutions for treating structural heart valve disease. Its ShortCut™ and Leaflex™ technologies are designed for minimally invasive cardiac procedures, particularly for patients undergoing TAVR.

Q3 2015 · Stake 2.2%

Anaconda Biomed

A Spanish medical device company specialised in advanced solutions for treating acute ischaemic stroke. Founded in Barcelona in 2015, it develops next-generation mechanical thrombectomy technologies; its flagship innovation is the ANA Funnel Catheter.

Q3 2016 · Stake 21.9%

Newronika

An Italian medtech company based in Milan developing advanced neurostimulation systems for neurological disorders, in particular Parkinson's disease, with adaptive deep brain stimulation (aDBS) technologies through the AlphaDBS platform.

Q4 2015 · Stake 26.49%

Angiodroid

An Italian medical device company developing automated CO₂ injector systems for vascular imaging procedures, using carbon dioxide as a contrast agent alternative to iodine, particularly for patients with renal insufficiency or contrast-medium allergies.

Q2 2015 · Stake 6.8%

THRON

An Italian technology company specialised in Digital Asset Management (DAM) and customer engagement solutions. Its AI-based platform enables companies to centralise, organise and distribute digital assets efficiently across multiple channels.

Q2 2014 · Stake 11.9%

SardexPay

An Italian fintech company providing digital payment and mutual-credit solutions to support local businesses and regional economies. Originating from the Sardex circuit in Sardinia, it enables SMEs to exchange goods and services through complementary currency systems.

Q2 2016 · Stake 12.9%

MioAssicuratore

An insurance platform and broker focused on multiple verticals — motor, marine, health and pets — helping customers find, compare, buy and manage policies more quickly and easily. The company is incubated by H-Farm and Pi Campus.

Q3 2018 · Stake 25.4%

Soulkitchen

An Italian food-tech company based in Milan developing semi-finished ingredients and ready-to-use food solutions for restaurants and retail, optimising food production through industrialised, data-driven processes.

Q1 2018 · Stake 18.3%

Let's build the next chapter, together.

Get in touch